Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

HEXO Corp.

HEXONASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.71
$0.02(2.45%)
U.S. Market is Open • 14:29

HEXO Corp. Fundamental Analysis

HEXO Corp. (HEXO) shows weak financial fundamentals with a PE ratio of -0.03, profit margin of -5.62%, and ROE of -2.06%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position422.36%
PEG Ratio-0.00

Areas of Concern

ROE-2.06%
Operating Margin-5.59%
Current Ratio0.81
We analyze HEXO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -774.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-774.0/100

We analyze HEXO's fundamental strength across five key dimensions:

Efficiency Score

Weak

HEXO struggles to generate sufficient returns from assets.

ROA > 10%
-1.58%

Valuation Score

Excellent

HEXO trades at attractive valuation levels.

PE < 25
-0.03
PEG Ratio < 2
-0.00

Growth Score

Weak

HEXO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

HEXO shows balanced financial health with some risks.

Debt/Equity < 1
0.80
Current Ratio > 1
0.81

Profitability Score

Weak

HEXO struggles to sustain strong margins.

ROE > 15%
-205.68%
Net Margin ≥ 15%
-5.62%
Positive Free Cash Flow
No

Key Financial Metrics

Is HEXO Expensive or Cheap?

P/E Ratio

HEXO trades at -0.03 times earnings. This suggests potential undervaluation.

-0.03

PEG Ratio

When adjusting for growth, HEXO's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values HEXO Corp. at 0.09 times its book value. This may indicate undervaluation.

0.09

EV/EBITDA

Enterprise value stands at 0.49 times EBITDA. This is generally considered low.

0.49

How Well Does HEXO Make Money?

Net Profit Margin

For every $100 in sales, HEXO Corp. keeps $-5.62 as profit after all expenses.

-5.62%

Operating Margin

Core operations generate -5.59 in profit for every $100 in revenue, before interest and taxes.

-5.59%

ROE

Management delivers $-2.06 in profit for every $100 of shareholder equity.

-2.06%

ROA

HEXO Corp. generates $-1.58 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.58%

Following the Money - Real Cash Generation

Operating Cash Flow

HEXO Corp. generates limited operating cash flow of $-184.95M, signaling weaker underlying cash strength.

$-184.95M

Free Cash Flow

HEXO Corp. generates weak or negative free cash flow of $-239.94M, restricting financial flexibility.

$-239.94M

FCF Per Share

Each share generates $-5.45 in free cash annually.

$-5.45

FCF Yield

HEXO converts -3.54% of its market value into free cash.

-3.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.03

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.09

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.22

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.80

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.81

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.06

vs 25 benchmark

ROA

Return on assets percentage

-1.58

vs 25 benchmark

ROCE

Return on capital employed

-3.09

vs 25 benchmark

How HEXO Stacks Against Its Sector Peers

MetricHEXO ValueSector AveragePerformance
P/E Ratio-0.0329.43 Better (Cheaper)
ROE-205.68%800.00% Weak
Net Margin-561.80%-20145.00% (disorted) Weak
Debt/Equity0.800.30 Weak (High Leverage)
Current Ratio0.814.64 Weak Liquidity
ROA-157.66%-17936.00% (disorted) Weak

HEXO outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews HEXO Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ